Redmile Group, LLC, 10% Owner at Aprea Therapeutics, Inc. (APRE), sold 994,137 shares at $5.58 ($5.5M) on 2020-12-28, disclosed to the SEC on 2021-02-16.
Open-market sale of $5.5M APRE by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.58 | 494,137 | $2.8M | 49.7% |
| 2 | $5.58 | 494,137 | $2.8M | 49.7% |
| 3 | $5.80 | 5,863 | $34K | 0.6% |
| Total | $5.58 avg | 994,137 | $5.5M | 100% |
| Filing → |
| FATE | BUY | 2023-12-28 | $332K | — | Filing → |
| IGMS | BUY | 2023-07-03 | $1.5M | — | Filing → |
| IGMS | SELL | 2023-07-03 | $1.5M | — | Filing → |